LoVE4MUM: Virtual Engagement for Preventing Postpartum Depression
NCT ID: NCT06366035
Last Updated: 2024-04-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
64 participants
INTERVENTIONAL
2024-04-22
2024-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Motherly on Postpartum Depression
NCT05055674
Preventing Perinatal Depression with an App-Based CBT Program
NCT06672432
A Virtual Support Intervention for Postnatal Well-being
NCT06557200
Behavioural Interventions for Postnatal Depression: a RCT Study
NCT03196726
EMA and mHealth in Preventing Postpartum Depression
NCT06777563
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary objective of this study is to preliminarily assess the effectiveness of a developed mobile application called LoVE4MUM in prevention of postpartum depression. The study will employ a single-blinded, pilot randomized controlled trial (RCT) design involving a sample of 64 mothers. Participants will be randomly assigned in a 1:1 ratio to one of two groups: the intervention group, which will receive standard postpartum care plus LoVE4MUM mobile application, or the control group, which will receive standard postpartum care alone. The primary outcome measure will be the effectiveness of the mobile application in improving symptoms of postpartum depression among mothers. Secondary outcome measures will include changes in postpartum mental health literacy scores and negative automatic thoughts frequencies.
Through the systematic evaluation of the LoVE4MUM mobile application in conjunction with standard postpartum care, this pilot RCT aims to generate preliminary evidence regarding the efficacy and feasibility of using mHealth tools for preventing postpartum depression.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment as Usual (TAU)
Mothers receiving treatment as usual (TAU) at the postpartum health care facilities according to standard guideline from period of delivery up to 6 weeks postpartum
No interventions assigned to this group
Treatment as Usual & LoVE4MUM phone application
Mothers receiving treatment as usual (TAU) and LoVE4MUM phone application from period of delivery up to 6 weeks postpartum
LoVE4MUM mobile application
LoVE4MUM is an innovative mobile application developed based on cognitive behavioral therapy and psychoeducation. The mobile application consist of 5 main modules which delivers information pertaining self-care, postpartum depression, handling negative thoughts, mood tracking and information for seeking help. The module consist of short notes, videos and worksheets for the participants to conduct.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LoVE4MUM mobile application
LoVE4MUM is an innovative mobile application developed based on cognitive behavioral therapy and psychoeducation. The mobile application consist of 5 main modules which delivers information pertaining self-care, postpartum depression, handling negative thoughts, mood tracking and information for seeking help. The module consist of short notes, videos and worksheets for the participants to conduct.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* mothers with access to smartphone and internet connectivity
* continue routine postpartum care at the government health facilities
* literate in english and malay
Exclusion Criteria
* diagnosis of depressive illness or any other mental health illness
* undergoing treatment for mental health
* infant born with intrauterine death or died immediately after birth
19 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health, Ministry of Health Malaysia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Siti Sabrina binti Kamarudin
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Siti Sabrina Kamarudin, MBBS
Role: PRINCIPAL_INVESTIGATOR
National Institute for Health, NIH Malaysia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Tengku Ampuan Rahimah
Klang, Selangor, Malaysia
Hospital Shah Alam
Shah Alam, Selangor, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Noor Fadzleeyanna Mohd Yahaya, MOG
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Kamarudin SS, Idris IB, Sharip S, Ahmad N. LoVE4MUM Mobile App to Prevent Postpartum Depression: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2025 Jan 27;14:e63564. doi: 10.2196/63564.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NMRR ID-24-00924-HPO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.